Cabergoline (Dostinex) Effect on Weight Ovarian Function

Cabergoline’s common brand name (Dostinex) is a long-acting dopamine receptor agonist, blocks prolactin secretion from the pituitary gland. It is used in Inhibition of physiological lactation, hyperprolactinaemia-associated disorders as polycystic ovarian syndrome, pituitary adenoma, and in Parkinson's disease; adjunct to levodopa treatment in Parkinson's disease. Common side effects of cabergoline; nausea, stomach upset, vomiting, constipation, heartburn, dizziness, tiredness, numbness, burning, and tingling in the hands, arms, legs, or feet. This report of two cases, take cabergoline showed a reduction in weight, resuming steady ovulation and regular menstruation after cabergoline treatment, with a possible side effect that these two cases developed follicular cyst following cabergoline treatment.